7.45 USD
↗ 0.01 (0.13%)AT CLOSE (11:59 AM EDT)
Kyverna Therapeutics, Inc. Common Stock
KYTXNASDAQ • USD
7.50
↗ 0.05 (0.63%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
7.50
↗ 0.05 (0.63%)
Market: CLOSED
Kyverna Therapeutics, Inc. Common Stock (KYTX) trades at $7.44 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics suggest KYTX is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Jul 17, 2026.
Open?$7.28
High?$7.67
Low?$7.19
Prev. Close?$7.44
Volume?874.3K
Avg. Volume?1.2M
VWAP?$7.48
Rel. Volume?0.71x
Bid / Ask
Bid?$6.37 × 100
Ask?$9.39 × 100
Spread?$3.02
Midpoint?$7.88
Valuation & Ratios
Market Cap?452.3M
Shares Out?60.8M
Float?36.8M
Float %?60.5%
P/E Ratio?N/A
P/B Ratio?2.31
EPS?-$2.57
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.
Themes
Employees
129
Market Cap
452.3M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2024-02-08
Address
5980 HORTON STREET
EMERYVILLE, CA 94608
Phone: (510) 626-8331
EMERYVILLE, CA 94608
Phone: (510) 626-8331
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?8
Momentum?77
Short Sent.?21
Piotroski F-Score?0/9Weak
Altman Z-Score?0.77Distress
Confidence?47%Low
Short InterestHigh
Short % of Float?19.63%High
Short Interest?7.2M
Days to Cover?4.6
Free Float36.8M
Avg Daily Volume1.6M
Settlement Date2026-06-30
Financial Health
Current Ratio?8.15Strong
Quick Ratio?8.15Strong
Cash Ratio?1.08Strong
Debt/Equity?0.13Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.31CHEAP▾
Peers100
S&P68
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-2.8CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-80.0%WEAK▾
S&P3
ROA?-60.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-150399000
Enterprise Value?$445.2M
Fundamentals ratios updated end of day